Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07214272 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Phase 4 Clinical Study to Investigate the Effectiveness and Safety of Skin Resurfacing

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 months later May 20, 2026 → Aug 24, 2026
See other at-risk trials from Bausch Health Americas, Inc.

Record History

  1. Primary completion pushed from May 20, 2026 to Aug 24, 2026 Completion date: Sep 2026 to Oct 6, 2026v7 Show 1 more changeShow less
    • Completion date: Sep 2026 to Oct 6, 2026
  2. Primary completion date changed from estimate of May 2026 to May 20, 2026v6
  3. Trial status: Recruiting to Active, Not Recruiting Enrollment target: estimated 50 to confirmed 49 · Site details revised at 5 of 5 sitesv5 Show 2 more changesShow less
    • Enrollment target: estimated 50 to confirmed 49
    • Site details revised at 5 of 5 sites
  4. Site contacts updated at 1 of 5 sitesv4
  5. Start date changed from estimate of Oct 2025 to Oct 17, 2025v3
  6. Trial status: Not Yet Recruiting to Recruiting Study sites: 1 to 5v2 Show 1 more changeShow less
    • Study sites: 1 to 5
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is a prospective, post-marketing (Phase 4) non-registrational single-arm, open-label, multicenter study.
Trial Details
NCT Number NCT07214272
Lead Sponsor Bausch Health Americas, Inc.
Conditions Skin Resurfacing
Enrollment 49 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov